Follow
Indira Nederpelt
Indira Nederpelt
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Kinetics for Drug Discovery: an industry-driven effort to target drug residence time
DA Schuetz, WEA de Witte, YC Wong, B Knasmueller, L Richter, DB Kokh, ...
Drug discovery today 22 (6), 896-911, 2017
1982017
Multiple binding sites for small-molecule antagonists at the CC chemokine receptor 2
AJM Zweemer, I Nederpelt, H Vrieling, S Hafith, MLJ Doornbos, ...
Molecular pharmacology 84 (4), 551-561, 2013
722013
Characterization of 12 GnRH peptide agonists–a kinetic perspective
I Nederpelt, V Georgi, F Schiele, K Nowak‐Reppel, ...
British journal of pharmacology 173 (1), 128-141, 2016
442016
Mechanistic models enable the rational use of in vitro drug-target binding kinetics for better drug effects in patients
WEA de Witte, YC Wong, I Nederpelt, LH Heitman, M Danhof, ...
Expert opinion on drug discovery 11 (1), 45-63, 2016
382016
Kinetic binding and activation profiles of endogenous tachykinins targeting the NK1 receptor
I Nederpelt, D Bleeker, B Tuijt, AP IJzerman, LH Heitman
Biochemical Pharmacology 118, 88-95, 2016
202016
Persistent GnRH receptor activation in pituitary αT3-1 cells analyzed with a label-free technology
I Nederpelt, RD Vergroesen, AP IJzerman, LH Heitman
Biosensors and Bioelectronics 79, 721-727, 2016
182016
From receptor binding kinetics to signal transduction; a missing link in predicting in vivo drug-action
I Nederpelt, M Kuzikov, WEA de Witte, P Schnider, B Tuijt, S Gul, ...
Scientific Reports 7 (1), 14169, 2017
142017
Kinetic profile of neuropeptide–receptor interactions
I Nederpelt, J Bunnik, AP IJzerman, LH Heitman
Trends in neurosciences 39 (12), 830-839, 2016
122016
Time is of the essence-investigating kinetic interactions between drug, endogenous
I Nederpelt
drug discovery & development 12 (4), 488-96, 2009
12009
The system can't perform the operation now. Try again later.
Articles 1–9